Compare Agilent Technologies Inc (A) vs Procter & Gamble Co (PG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Agilent Technologies Inc vs Procter & Gamble Co — how do they compare? Agilent Technologies Inc trades at $128.97 (market cap $37.04B), while Procter & Gamble Co trades at $149.21 (market cap $355.69B). The key difference: Procter & Gamble Co is far larger — about 9.6× Agilent Technologies Inc's market cap, and Procter & Gamble Co pays the higher dividend (2.79%). Which is the better fit depends on your goals.
| A | PG | |
|---|---|---|
Market Cap | $37.04B | $355.69B |
Sector | Health | Consumer Staples |
52-Week High | $157.20 | $167.18 |
52-Week Low | $110.24 | $138.10 |
Enterprise Value | $38.59B | $381.17B |
Dividend Yield | 0.78% | 2.79% |
Volume | — | 6,423,436 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
Procter & Gamble (PG) trades at $149.83, up 0.35% today, with a bullish technical signal from moving averages and ADX indicators. The company maintains strong profitability with a 19.16% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights include a new WNBA partnership and ongoing supply chain improvements, while analyst consensus remains positive with a $159.88 price target.
PG offers stable growth and reliable dividends, supported by consistent cash flow and 69 years of dividend increases. Risks include premium valuation multiples and modest revenue growth outlook. The stock presents a defensive investment opportunity amid market volatility, with upside potential aligned with analyst targets but sensitivity to consumer demand fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
